PGI8 An Exploratory Analysis of the Survival Benefits in Commercially Insured Patients with Hepatic Encephalopathy (HE) Treated with Rifaximin versus Lactulose Alone using US Claims Data
Abstract
Authors
R. Burne M.L. Volk A. Guerin S. Shi G. Joseph Z. Heimanson M. Ahmad